SRENEUTRAL

P/E Ratio

32.5x

Updated 606h ago

Sector Performance

68th percentile

SRE

32.5x

Sector Median

24.7x

Sector Avg

36.0x

📊

Deep Analysis

The current P/E ratio of 32.5x means that investors are paying $32.50 for every $1 of the company’s annual earnings, a common gauge of how expensive the stock is relative to its profit.

Among sector peers, this is well above the sector median of 24.9x, placing SRE in the 69th percentile—more expensive than most comparable companies. Over the last eight quarters, the P/E trend is decreasing, though the most recent quarter-over-quarter change shows a +5.7% increase from 30.7x to 32.5x; the year-over-year change is not available. The combination of a high P/E (above median) with a longer-term decreasing trend suggests that while valuation remains elevated, the prior compression could reduce downside risk if earnings grow to justify the multiple. This mixed picture—expensive relative to peers but with a downward trend—supports the overall NEUTRAL verdict by offering neither a clear bargain nor an obvious overvaluation signal.

Frequently Asked Questions

What does the P/E Ratio tell investors about SRE?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

Who are SRE's closest peers by P/E Ratio?

The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

Advertisement

Master SRE's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full SRE research report

Free account — no credit card

SRE

32.5x

Sector Median

24.7x

Sector Avg

36.0x

How SRE's P/E Ratio compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.